Recent

% | $
Quotes you view appear here for quick access.

Aethlon Medical, Inc. Message Board

andy55q 76 posts  |  Last Activity: 19 hours ago Member since: Feb 2, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    New link on Cytosorbents Facebook

    by longctso Jul 29, 2015 11:54 AM

    This review outlines the use of extracorporeal therapies in the treatment of sepsis and septic AKI, considering the classic aspects of extracorporeal renal replacement therapy including indications, timing, and delivered dose but also discussing the various techniques that are currently used to achieve immune homeostasis. The authors further discuss the evidence accumulated to date and suggest possibilities for the future treatment of this entity of patients. In this context, the CytoSorb therapy is mentioned as one of the most promising approaches, due to its improved biocompatibility and therefore the opportunity for whole blood hemoperfusion, its efficiency in removing multiple inflammatory mediators shown in animals studies as well as in case reports and due to its beneficial effects on chemokine gradients, which may restore chemokine gradients towards infected tissue and away from healthy organs through leukocyte trafficking control.

  • Reply to

    Cytosorb Registry and EAP

    by luvboats2003 Jul 24, 2015 4:05 PM
    andy55q andy55q Jul 27, 2015 9:34 PM Flag

    Same here

  • Reply to

    Now for some reality

    by ctsoforlife Jun 7, 2015 8:55 PM
    andy55q andy55q Jul 27, 2015 10:46 AM Flag

    Any update ??

  • In addition to numerous prospective study projects CytoSorbents also has marketing experience in the context of larger case series from the indications of septic shock, cardiac surgery, lung transplantation, liver failure and others.
    Upon completion of the retrospective analysis, we expect mid-2015 several publications.
    The number of published reports on individual treatments is steadily growing and already covers a wide area of CytoSorb-applications. A selection of published and unpublished case reports can be found here:

  • Reply to

    TekMed

    by kenve62 Jul 24, 2015 4:40 PM
    andy55q andy55q Jul 26, 2015 2:28 PM Flag

    ANZICS/ACCCN ASM 2015, 40th Annual Scientific Meeting of the Australia and New Zealand Intensive Care Society and Australian College of Critical Care Nurses is starting on 29 October, 2015 and ending on 31 October, 2015.
    Exhibitors
    TekMed supply a complete range of Blood Purification Devices for the ICU.
    • CytoSorb: an extracorporeal blood purification therapy designed to reduce excessive levels of inflammatory mediators such as cytokines, or “cytokine storm”, from blood. In doing so, the goal is to reduce the potentially deadly systemic inflammatory response syndrome (SIRS) seen in life-threatening inflammatory conditions. CytoSorb columns fit onto all CRRT machines in ANZ
    • Infomed HF440 CRRT machines and kits
    o Complete range of therapies
    o Reduced “off treatment” time
    o “no touch” waste handling
    o Extended pressure mode for hookup to ECMO
    • Vascular access catheters for CRRT
    o FreeFlow 360° inlet – great flows
    o SDL silicon 13.5 fr – non kink 15-32cm insertion lengths"

    Sentiment: Buy

  • Reply to

    New Abstact On Facebook Cytosorb Trauma

    by berthabluefish Jul 24, 2015 8:36 AM
    andy55q andy55q Jul 24, 2015 8:51 AM Flag

    DIVI Research Award / Poster Competition

    The DIVI sees itself as a scientific society and the scientific discussion would give a higher profile. Therefore we have created a new format to back as an abstract submitted work more at the center of the Congress and a higher monetary value.
    The eight best abstracts will be selected by an assessment committee before Congress. The eight award winners will then at a symposium in front of a high-profile jury of experts against each other, each prize winner can present his work here as part of a fifteen-minute lecture. The expert jury selects the winners immediately after the symposium from, are being awarded for the winner #$%$ 2.000, the second #$%$ 1,500, the third #$%$ 1,000 and as for the places 4-8 per 500.- #$%$.

  • Steffen Martens
    Andreas Pendleder
    cytosorb-therapy

    Sentiment: Buy

  • andy55q andy55q Jul 22, 2015 11:44 AM Flag

    Another application is in cancer immunotherapy. CytoSorb® was specifically designed to treat "cytokine release syndrome (CRS)" or cytokine storm. We believe that it can be used as a rescue therapy, when patients develop uncontrolled CRS in activated T-cell or CAR T-cell cancer immunotherapy. Cancer cachexia is another potential opportunity. Cancer cachexia is a wasting condition that occurs in most cancers that leads to rapid uncontrolled weight loss, anorexia, and physical debilitation. Patients lose the physical reserve needed to tolerate treatment and fight the cancer. Because CytoSorb® can remove a broad range of cytokines and other inflammatory mediators that drive cancer cachexia, it may be very helpful in this condition. CytoSorbents is exploring this application, as well as the use of CytoSorb® as a primary cancer immunotherapy to kickstart the immune system to attack cancer, with researchers at the University of Pennsylvania School of Veterinary Medicine.

  • Reply to

    47 PARTICIPATING CLINICAL CENTERS

    by andy55q Jul 22, 2015 8:45 AM
    andy55q andy55q Jul 22, 2015 10:23 AM Flag

    Go to IHUB for link.
    Welcome to the International CytoSorb-Registry website!

  • These hospitals have already registered for participation:

    Germany
    University Hospital Ulm
    University Hospital Göttingen
    Hospital Emden
    University Hospital Rostock
    University Hospital Greifswald
    Ev. Hospital Bielefeld
    University Hospital Oldenburg
    Heart and Diabetes Center Bad Oeynhausen
    University Hospital Hamburg-Eppendorf
    University Hospital Essen
    University Hospital Munich Rechts der Isar
    University Hospital Düsseldorf
    Hospital Barmherzige Brüder Munich
    Hospital St. Elisabeth und St. Barbara Halle
    Hospitals Nordoberpfalz
    Vivantes Hospital Berlin Neukölln
    University Hospital Freiburg
    St. Johannes Hospital Dortmund
    Asklepios Hospital Hamburg
    Carl-Thiem-Hospital Cottbus
    University Hospital Bergmannsheil Bochum
    Agaplesion Hospital Rotenburg
    Universitätsklinikum Schleswig-Holstein, Lübeck
    Klinikum Region Hannover
    Maria Hilf Klinik Mönchengladbach

    Switzerland
    University Hospital Zurich

    Austria
    Hospital Hietzing Vienna
    University Hospital Innsbruck
    Medizinische Universität Wien

    Hungary
    University Hospital Szeged
    University Hospital Debrecen
    Semmelweis Universität, Budapest

    Netherlands
    VieCuri Medical Center Noord-Limburg
    Maasstadziekenhuis Rotterdam
    Ziekenhuis De Tongerschans, Heerenveen
    Laurentius Ziekenhuis Roermond
    ISALA-Klinik, Zwolle, NL

    Belgium
    Erasme Hospital Brussels

    Egypt
    Ain Shams University, Kairo

    Romania
    Fundeni Clinical Insitute Bucharest
    University County Emergency Hospital Timi?oara
    Emergency County Hospital Cluj

    India
    Muljibhai Patel Urological Hospital

    Colombia
    Clinica de la Mujer, Bogotá

    Bulgaria
    Cardio Center Pontika, Burgas

    UK
    Harefield Hospital Middlesex

    Italy
    Nuovo Ospedale Civile Sant Agostino Estense, Modena

    Sentiment: Buy

  • Reply to

    EAP could not come soon enough

    by kgrichard5 Jul 15, 2015 8:11 AM
    andy55q andy55q Jul 15, 2015 8:27 AM Flag

    What City/State?

    Sentiment: Buy

  • Reply to

    Sepsis News

    by saluda_bound Jul 7, 2015 9:51 PM
    andy55q andy55q Jul 7, 2015 10:46 PM Flag

    Go to IHUB. I posted 2 articles

  • Prof Brunkhorst, general secretary of the German Sepsis Society and PI of Cytosorb patient register, was today the ARD Buffet to visit and explained about sepsis.

  • andy55q andy55q Jul 1, 2015 10:42 PM Flag

    What is sepsis and why is it so dangerous?
    Sepsis a severe health problem sparked by your body’s reaction to infection. When you get an infection, your body fights back, releasing chemicals into the bloodstream to kill the harmful bacteria or viruses. When this process works the way it is supposed to, your body takes care of the infection and you get better. With sepsis, the chemicals from your body’s own defenses trigger inflammatory responses, which can impair blood flow to organs, like the brain, heart or kidneys. This in turn can lead to organ failure and tissue damage.

  • andy55q andy55q Jul 1, 2015 10:37 PM Flag

    Posted info on IHUB

  • Reply to

    Numbers update from EXIM

    by saluda_bound Jun 8, 2015 1:55 PM
    andy55q andy55q Jul 1, 2015 11:29 AM Flag

    7/1/2015 $1,580,402.00

  • The time for filing a petition for review of the initial decision in this proceeding has
    expired. No such petition has been filed by AuraSound, Inc., C2C CrowdFunding, Inc.,
    Convenience TV Inc., or NewMarket Technology, Inc., and the Commission has not chosen to
    review the decision on its own initiative.
    Accordingly, notice is hereby given, pursuant to Rule 360(d) of the Commission's Rules
    of Practice,1 that the initial decision of the administrative law judge has become the final
    decision of the Commission with respect to AuraSound, Inc., C2C CrowdFunding, Inc.,
    Convenience TV Inc., and NewMarket Technology, Inc.
    2 The order contained in that decision is hereby declared effective. The initial decision ordered that, pursuant to Section 12(j)
    of the Securities Exchange Act of 1934, the registrations of each class of registered securities of
    AuraSound, Inc., C2C CrowdFunding, Inc., Convenience TV Inc., and NewMarket Technology,
    Inc., are revoked.

  • andy55q andy55q Jun 28, 2015 4:42 PM Flag

    I posted the info on IHUB

  • Lunch-Symposium, 10.09.2015, 12:00 – 13:30
    SIRS and Sepsis – regain control with CytoSorb therapy
    Chair: Weigand M, Heidelberg; Molnar Z, Szeged

    How can CytoSorb modulate the excessive immune response?
    Gerlach H, Berlin

    Clinical results of a septic shock study
    Molnar Z, Szeged

    Use of CytoSorb® in patients with severe sepsis and septic shock - when
    is it best to start?
    Nierhaus A, Hamburg

    The international CytoSorb registry – current status
    Brunkhorst FM, Jena

    Supported by Cytosorbents Europe GmbH

    Sentiment: Buy

  • GEOMC Co., LTD. Took a Legal Action in Recovering the Inventory of the Scrambler Therapy Device in the US
    SEOUL, South Korea, /PRNewswire/ -- GEOMC Co., LTD. announced today that it filed a Complaint in the United States District Court, District of Connecticut to take possession of the inventory of the Scrambler Therapy Device held by Competitive Technologies, Inc. ("CTTC" or "CTI"). The majority of the inventory has been secured under the UCC filing by GEOMC. CTI has refused to return the inventory in spite of GEOMC's repeated requests since 2013.

AEMD
9.44-0.11(-1.15%)2:14 PMEDT